1.King, H., Aubert, R. and Herman,W. 1998. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections. Diab. Care. 21: 1414-1431.
2.Tolman, K.G. and Chandramouli, J. 2003. Hepatotoxicity of the thiazolidinediones. Clin. Liver. Dis. 7: 369-379.
3.Venkatesh, S., Reddy, G.D., Reddy, B.M., Ramesh, M. and Rao, A.V. 2003. Antihyperglycemic activity of Caralluma attenuata. Fitoterapia. 74: 274-279.
4.Grover, J.K. and Yadav, S.P. 2004. Pharmacological actions and potential uses of Momordica charantia: A review". J. Ethnophar. 93: 123-132.
5.Paul, A. and Raychaudhuri, S.S.2010. Medicinal uses and molecular identification of two Momordica charantia varieties-a review Elec. J. Biol. 6: 43-51.
6.Khanna, P., Jain, S.C., Panagariya, A. and Dixit, V.P. 1981. Hypoglycemic activity of polypeptide-P from a plant source. J. Nat. Prod. 44: 648-655.
7.Wang, B.L., Zhang, W.J., Zhao, J., Wang, F.J., Fan, L.Q., Wu, Y.X. and Hu, Z.B. 2011. Gene cloning and expression of a novel hypoglycaemic peptid from Momordica charantia. J. Sci. Food. Agri. 91: 2443-2448.
8.Fu, Z.P., Liu, H.Y., Lu, L., Chen,Z.J., Zhou, J.Y. and Wang, F.J.2009. Protection of protease inhibitorof Momordica charantia on activityof hypoglycemic peptides fromM. charantia. Chin. Tradit. Herbal. Drugs. 40: 1259-1262.
9.Grover, J.K., Yadav, S. and Vats, V. 2002. Medicinal plants of India with antidiabetic potential. J. Ethnopharmacol. 81: 81-100.
10.Croteau, R., Ketchum, R.E.B., Long, R.M., Kaspera, R. and Wildung, M.R. 2006. Taxol biosynthesis and molecular genetics. Phytochem. Rev. 5: 75-97.
11.Jung, W., Yu, O., Lau, S.M.C., O’Keefe, D.P., Odell, J., Fader, G. and McGonigle, B. 2000. Identification and expression of isoflavone synthase, the key enzyme for biosynthesis of is of lavones in legumes. Nat. Biotechnol.18: 208-212.
12.Hanahan, D. 1983. Studies on transformation of Eschericliia coli with plasmids. J. Mol. Biol. 166: 557-580.
13.Sambrook, J. and Russell, D.W.2001. Molecular cloning: A laboratory manual. Third edition, Cold spring harbor, New York.
14.Kelley, L.A., Mezulis, S., Yates, C.M., Wass, M.N. and Sternberg, M.J.E. 2015. The Phyre2 web portal for protein modeling, prediction and analysis. Nature Prot. 10: 845-858.
15.Sanger, F., Nicklen, S. and Coulson, A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74: 5463-5467.
16.Tian, M., Zeng, X.Q., Song, H.L., Hu, S.X., Wang, F.J., Zhaob, J. and Hu,Z.B. 2015. Molecular diversity and hypoglycemic polypeptide-P content of Momordica charantia in different accessions and different seasons. J. Sci. Food. Agri. 95: 1328-1335.
17.Jafari, D. and Dehgan-Nayeri, F. 2018. Isolation and bioinformatics study of TbJAMYC transcription factor involved in biosynthesis of Taxol from Iranian yew. Iranian J. Ran. Fores. Plant. Breed. Gen. Res. 26: 12-22.
18.Nims, E., Vongpaseuth, K., Roberts, S.C. and Walker, E.L. 2015. TcJAMYC: A bHLH transcription factor that activates paclitaxel biosynthetic pathway genes in yew.
J. Biol. Chem. 14: 290.
19.
Levy, E.,
Spahis, S.,
Ziv, E.,
Marette, A.,
Elchebly, M.,
Lambert, M.,and
Delvin, E. 2006. Overproductionof intestinal lipoprotein containing apolipoprotein B-48 in
Psammomys obesus: impact of dietary n-3 fatty acids.
Diabetol. 49: 1937-45.